Albertsons Stock (ACI) Slumps as Boss Announces Full Business Review and Annual Guidance Delay

Albertsons (ACI) shares fell after CEO Susan Morris announced a full business review and delayed annual guidance. Q2 earnings per share beat estimates at $0.36, but revenue declined slightly to $18.89B. Pharmacy and digital sales grew, while net income dropped to $51.5M. The company also seeks $9B from Kroger over a failed merger. Analysts have a Hold consensus with a $13 price target.

Original reporting
Published Oct 13, 2026, 1:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 2:54 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ACI
Bearish
high confidence
Mentioned
$ACI
Relevance
7/10
AlphAI data visualization · based on tipranks.com
Decision brief

The 30-second read

$ACIBearishMed
01

Why it matters

The mixed signal may trigger short‑term volatility while longer‑term investors watch for operational improvements.

02

Market read

Earnings beat tempered by guidance delay creates near‑term downside risk.

03

What to watch

Potential upside from digital sales growth and fuel revenue offsets.

Relevance 7/10Novelty 7/10Timing: today

Background

Albertsons (ACI) announced Q2 results, beat EPS expectations, but postponed its annual outlook pending a business review.

Company-level read

Ticker impact

$ACIBearishHigh confidence
Context

Albertsons reported Q2 earnings with a beat on EPS but delayed its annual guidance, indicating operational concerns.

Expected impact

downward pressure as investors reassess outlook

Evidence & confidence

Guidance delays often trigger short-term sell‑offs despite earnings beats.

Market effects

Grocery sector may see heightened scrutiny on cost‑control initiatives.

U.S. consumer‑discretionary sentiment could soften.

Limited to U.S. retail investors.

Counterpoint

The earnings beat and strong pharmacy sales could support a rebound if the review yields cost cuts.

Key entities

  • Albertsons Companies

    U.S. grocery retailer reporting earnings and guidance delay.

Related articles

$ACILow

Albertson Falls on Transition at Top

Albertsons (ACI) announced Tom Moriarty, EVP and General Counsel, is stepping down but will advise until 2027. Elena Dietrich will serve as interim General Counsel. CEO Susan Morris thanked Moriarty for his contributions. Moriarty cited the merger trial's end as the right time for transition.

$ACIMedAI 8/10

Albertsons Faces $900 Million Judgment In Washington Opioid Case

Albertsons was ordered to pay $900 million for its role in Washington's opioid crisis. A judge ruled the company repeatedly filled suspicious prescriptions, violating state consumer protection laws. The verdict includes $800 million for abatement and $100 million in penalties, according to the ruling.

$ACILow

Albertsons Appoints Andrew Murray as CFO for 2027

Albertsons appointed Andrew Murray as CFO, effective January 2027. Murray, currently CFO at Fonterra, will succeed interim CFO Cody Perdue. The move is part of Albertsons' efforts to simplify operations and control costs. Murray's compensation includes a $900,000 base salary and potential bonuses and equity awards. The company withdrew its fiscal 2026 outlook in October.

$ACIMed

Albertsons taps outsider Andrew Murray as CFO amid business review

Albertsons named Andrew Murray as CFO starting January 17, 2024, to lead a business review aimed at improving sales through cost cuts and lower prices. Murray, currently CFO of Fonterra, has experience in consumer sectors. CEO Susan Morris cited Murray's transformation expertise as valuable during this 'critical turnaround time'. Murray replaces interim CFO Cody Perdue, following Sharon McCollam's retirement. Albertsons withdrew its 2026 forecasts in October despite beating Q2 profit estimates.